CLA-2-30:OT:RR:NC:N3:138
Rosie Hipwell
Bluepoint Labs
8 Eastgate Avenue, Eastgate Business Park
Little Island, Cork Ireland
RE: The tariff classification of Cisplatin Injection in dosage form, from India
Dear Ms. Hipwell:
In your letter dated November 23, 2023, you requested a tariff classification ruling.
Cisplatin Injection, imported in 1 mg/mL vials, is a sterile aqueous solution containing a mixture of 1 mg of Cisplatin, sodium chloride in water for injection, sodium hydroxide and hydrochloric acid as pH adjusting agents. Cisplatin Injection is indicated for the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
The applicable subheading for the Cisplatin Injection in dosage form will be 3004.90.9215, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Antineoplastic and immunosuppressive medicaments.” The rate of duty will be free.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/current.
The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request. This position is clearly set forth in Title 19, Code of Federal Regulations (CFR), Section 177.9(b)(1). This section states that a ruling letter is issued on the assumption that all of the information furnished in the ruling letter, whether directly, by reference, or by implication, is accurate and complete in every material respect. In the event that the facts are modified in any way, or if the goods do not conform to these facts at time of importation, you should bring this to the attention of U.S. Customs and Border Protection (CBP) and submit a request for a new ruling in accordance with 19 CFR 177.2. Additionally, we note that the material facts described in the foregoing ruling may be subject to periodic verification by CBP.
This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at [email protected].
Sincerely,
Steven A. Mack
Director
National Commodity Specialist Division